The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2022
Filed:
Aug. 14, 2018
Applicant:
Psomagen, Inc., Rockville, MD (US);
Inventors:
Zachary Apte, San Francisco, CA (US);
Jessica Richman, San Francisco, CA (US);
Daniel Almonacid, San Francisco, CA (US);
Valeria Marquez, San Francisco, CA (US);
Ingrid Araya, San Francisco, CA (US);
Melissa Alegria, San Francisco, CA (US);
Mario Saavedra, San Francisco, CA (US);
Luis Gomez, San Francisco, CA (US);
Janyra Espinoza, San Francisco, CA (US);
Javier Gimpel, San Franscisco, CA (US);
Eduardo Morales, San Francisco, CA (US);
Rodrigo Ortiz, San Francisco, CA (US);
Assignee:
Psomagen, Inc., Rockville, MD (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 15/00 (2019.01); G16B 5/00 (2019.01); A61K 31/047 (2006.01); A61P 9/10 (2006.01); A61K 31/40 (2006.01); A61K 31/045 (2006.01); A61K 31/4409 (2006.01); A61K 31/166 (2006.01); A61K 31/05 (2006.01); A61K 31/4196 (2006.01); A61K 31/12 (2006.01); A61K 31/14 (2006.01); A61K 31/415 (2006.01); A61K 31/192 (2006.01); A61K 31/4406 (2006.01); A61K 31/216 (2006.01); G16B 15/30 (2019.01); A61K 31/015 (2006.01); A61P 31/04 (2006.01); A61P 13/12 (2006.01); A61K 31/075 (2006.01); A61K 31/085 (2006.01); A61K 31/11 (2006.01); A61K 31/121 (2006.01); A61K 31/122 (2006.01); A61K 31/133 (2006.01); A61K 31/136 (2006.01); A61K 31/15 (2006.01); A61K 31/16 (2006.01); A61K 31/164 (2006.01); A61K 31/165 (2006.01); A61K 31/167 (2006.01); A61K 31/185 (2006.01); A61K 31/198 (2006.01); A61K 31/22 (2006.01); A61K 31/222 (2006.01); A61K 31/235 (2006.01); A61K 31/26 (2006.01); A61K 31/277 (2006.01); A61K 31/336 (2006.01); A61K 31/341 (2006.01); A61K 31/343 (2006.01); A61K 31/357 (2006.01); A61K 31/36 (2006.01); A61K 31/365 (2006.01); A61K 31/37 (2006.01); A61K 31/381 (2006.01); A61K 31/4015 (2006.01); A61K 31/4035 (2006.01); A61K 31/404 (2006.01); A61K 31/41 (2006.01); A61K 31/4192 (2006.01); A61K 31/42 (2006.01); A61K 31/4245 (2006.01); A61K 31/428 (2006.01); A61K 31/4355 (2006.01); A61K 31/437 (2006.01); A61K 31/439 (2006.01); A61K 31/44 (2006.01); A61K 31/4402 (2006.01); A61K 31/4418 (2006.01); A61K 31/4425 (2006.01); A61K 31/4465 (2006.01); A61K 31/50 (2006.01); A61K 31/502 (2006.01); A61K 31/517 (2006.01); A61P 1/12 (2006.01);
U.S. Cl.
CPC ...
G16B 15/00 (2019.02); A61K 31/015 (2013.01); A61K 31/045 (2013.01); A61K 31/047 (2013.01); A61K 31/05 (2013.01); A61K 31/075 (2013.01); A61K 31/085 (2013.01); A61K 31/11 (2013.01); A61K 31/12 (2013.01); A61K 31/121 (2013.01); A61K 31/122 (2013.01); A61K 31/133 (2013.01); A61K 31/136 (2013.01); A61K 31/14 (2013.01); A61K 31/15 (2013.01); A61K 31/16 (2013.01); A61K 31/164 (2013.01); A61K 31/165 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61K 31/185 (2013.01); A61K 31/192 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 31/22 (2013.01); A61K 31/222 (2013.01); A61K 31/235 (2013.01); A61K 31/26 (2013.01); A61K 31/277 (2013.01); A61K 31/336 (2013.01); A61K 31/341 (2013.01); A61K 31/343 (2013.01); A61K 31/357 (2013.01); A61K 31/36 (2013.01); A61K 31/365 (2013.01); A61K 31/37 (2013.01); A61K 31/381 (2013.01); A61K 31/40 (2013.01); A61K 31/404 (2013.01); A61K 31/4015 (2013.01); A61K 31/4035 (2013.01); A61K 31/41 (2013.01); A61K 31/415 (2013.01); A61K 31/4192 (2013.01); A61K 31/4196 (2013.01); A61K 31/42 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/437 (2013.01); A61K 31/439 (2013.01); A61K 31/4355 (2013.01); A61K 31/44 (2013.01); A61K 31/4402 (2013.01); A61K 31/4406 (2013.01); A61K 31/4409 (2013.01); A61K 31/4418 (2013.01); A61K 31/4425 (2013.01); A61K 31/4465 (2013.01); A61K 31/50 (2013.01); A61K 31/502 (2013.01); A61K 31/517 (2013.01); A61P 9/10 (2018.01); A61P 13/12 (2018.01); A61P 31/04 (2018.01); G16B 5/00 (2019.02); G16B 15/30 (2019.02);
Abstract
Embodiments of a method and/or system can include administering, to a patient with one or more conditions associated with at least one of TMA, TMAO, and/or derivatives thereof, a therapeutically effective amount of a compound for affecting inhibiting one or more CutC enzymes and/or CntA enzymes associated with microorganisms from at least one taxon from a set of microorganism taxa.